FTC contests support over brain health advertising claims
USA
Jan 26, 2022
The Federal Trade Commission (FTC) pushed back against arguments made by Quincy Bioscience that its advertising claims for Prevagen—a brain health supplement—are supported by “competent and reliable scientific evidence.”
According to the complaint, the defendants represented in national TV ads and elsewhere that Prevagen improves memory within 90 days, reduces memory problems associated with aging, and provides other cognitive benefits, like healthy brain function, a sharper mind, and clearer thinking. What’s more, they claimed to have clinical proof to support their advertising promises.
For further information (in English), click on the Link
ASA weighs in on health-boosting claim about superfoods
UK
Sep 27, 2024
MFDS proposes to modify labeling requirements on claims related to hangover relief
South Korea
Aug 22, 2024
Japan proposes amendment to Health Promotion Act related to labeling of special-purpose foods
Japan
Aug 09, 2024
SAMR opens up channels for companies to recommend new health claims
China
Aug 05, 2024
Commission refusing health claim related to isomaltulose and energy metabolism
European Union
Aug 05, 2024
Commission rejects health claim for monacolin K from red yeast fermented rice
European Union
Jul 31, 2024
UK rules against treat anxiety claims
UK
Jul 24, 2024
Philippines publishes draft guidelines on nutrition and health claims
Philippines
Jul 10, 2024
India approves proposal for bolder nutritional information on food labelling
India
Jul 09, 2024
UK rules against mental performance claims
UK
Jul 02, 2024
ASA rules on false arthritis treatment claim
UK
Jun 28, 2024
UK rules on claims relating to menopause symptoms breaching the Code
UK
Jun 26, 2024
Japan proposes partial revision of regulation on function claims
Japan
Jun 26, 2024
New ASA Ruling on comparative nutrition claims
UK
May 31, 2024
FSANZ amends Code's section about added sugar(s) claims for typographical error
Australia
May 17, 2024
